StonvexLoading…
StonvexStonvexStonvexCore line items from ARRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $223.41M | $1.28B | $1.06B | $664.61M |
Operating Income | $7.11M | $-29.00M | $119.11M | $73.66M |
Net Income | $2.00M | $-52.23M | $93.51M | $60.01M |
EPS (Diluted) | $-0.09 | $-0.73 | $0.32 | $0.20 |
Total Assets | $1.48B | $1.45B | $1.61B | $1.54B |
Total Liabilities | $1.21B | $1.19B | $1.21B | $1.18B |
Cash & Equivalents | $200.70M | $244.39M | $221.52M | $377.27M |
Free Cash Flow OCF − CapEx | $-36.93M | $79.81M | $43.65M | $21.80M |
Shares Outstanding | 152.96M | 152.54M | 153.35M | 152.96M |